EUVIMEDEUVIMED entdecken
Evaluationsstudie

Evaluating immunocytochemistry performance in lung cancer cytology: An IASLC Cytology Working Group study

Deepali Jain iD, Irena Srebotnik-Kirbis iD, Aruna Nambirajan, Marianne Engels, Izidor Kern, Tae-Jung Kim, Maria Dolores Lozano iD, Yuko Minami, Noriko Motoi, Mauro Papotti, Natasha Rekhtman, Anjali Saqi iD und 5 weitere

Cancer Cytopathology · 2026-11 · 134 (11)

DOI: 10.1002/cncy.70159 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Cancer Cytopathology, online erschienen am 12.10.2026. Verfasst von Deepali Jain und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, All India Institute of Medical Sciences, New Delhi, Delhi, India. Hauptthemen laut MEDLINE: Lung Neoplasms, Immunohistochemistry, Carcinoma, Non-Small-Cell Lung, Cytodiagnosis. Die Arbeit nennt 21 Literaturangaben. Gefördert von: International Association for the Study of Lung Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunohistochemistry (IHC) is essential for tumor subtyping and predictive biomarker analysis in non–small cell lung carcinoma (NSCLC). When only cytological material is available and no concurrent biopsy or cell block exists, immunocytochemistry (ICC) may need to be performed on slides prepared using diverse fixation protocols, introducing substantial pre‐analytical variability.

Methods

Seven laboratories representing commonly used cytology fixation protocols were selected based on an exploratory global survey of 63 institutions. Two central laboratories prepared direct smears, cytospins and provided cells in PreservCyt from specimens with confirmed marker expression using the selected fixation protocols. Materials were distributed for immunocytochemical demonstration of TTF‐1, p40, ALK , and ROS1 according to local protocols. Digitized slides were independently evaluated using standardized four‐tier scoring criteria.

Result

A total of 105 stained slides from 17 study runs were assessed. Delaunay‐fixed, Papanicolaou‐stained, and methanol‐fixed polyethylene glycol‐coated preparations demonstrated consistently superior ICC performance compared with other evaluated fixation protocols. In contrast, high rates of suboptimal staining were observed with PreservCyt fixation (81.8%) and air‐dried preparations (58.8%).

Conclusions

This study demonstrates that fixation protocol significantly impacts ICC performance on non–cell block cytological preparations. The observed fixation‐dependent differences underscore the need for harmonized pre‐analytical practices, robust local validation, and external quality assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsImmunohistochemistryCarcinoma, Non-Small-Cell LungCytodiagnosisBiomarkers, TumorTissue FixationHumans

Stichwörter der Autor:innen

fixationimmunocytochemistrylung cancernon–cell block cytologyquality assessment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, Delhi, India.
  • Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Institute of Pathology, University of Cologne, Medical Faculty, Cologne, Germany.
  • Cytology and Pathology Laboratory, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.
  • Department of Hospital Pathology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

ORCID-Profile: Deepali Jain, Irena Srebotnik-Kirbis, Maria Dolores Lozano, Anjali Saqi, Lukas Bubendorf

Förderung

  • International Association for the Study of Lung Cancer

Zitieren

APA

Jain, D., Srebotnik-Kirbis, I., Nambirajan, A., Engels, M., Kern, I., Kim, T. J., Lozano, M. D., Minami, Y., Motoi, N., Papotti, M., Rekhtman, N., Saqi, A., Schönegg, R., Wynes, M. W., Yatabe, Y., Bubendorf, L., & IASLC Pathology Committee Members (2026). Evaluating immunocytochemistry performance in lung cancer cytology: An IASLC Cytology Working Group study. Cancer Cytopathology, 134(11). https://doi.org/10.1002/cncy.70159

Vancouver

Jain D, Srebotnik-Kirbis I, Nambirajan A, Engels M, Kern I, Kim TJ, et al. Evaluating immunocytochemistry performance in lung cancer cytology: An IASLC Cytology Working Group study. Cancer Cytopathology. 2026;134(11). doi:10.1002/cncy.70159

BibTeX
@article{Jain2026,
  author = {Jain, Deepali and Srebotnik-Kirbis, Irena and Nambirajan, Aruna and Engels, Marianne and Kern, Izidor and Kim, Tae-Jung and Lozano, Maria Dolores and Minami, Yuko and Motoi, Noriko and Papotti, Mauro and Rekhtman, Natasha and Saqi, Anjali and Schönegg, René and Wynes, Murry W and Yatabe, Yasushi and Bubendorf, Lukas and IASLC Pathology Committee Members, IASLC Pathology Committee Members},
  title = {Evaluating immunocytochemistry performance in lung cancer cytology: An IASLC Cytology Working Group study},
  journal = {Cancer Cytopathology},
  year = {2026},
  volume = {134},
  number = {11},
  doi = {10.1002/cncy.70159}
}
Kostenlos starten →